The 2025 YouGov survey data from more than 31,000 US adults show significant support for recreational cannabis legalization, medical use, and federal reclassification.
Feature|Videos|April 27, 2023
Cannabis Science Conference Live: Eloise Theisen, RN
Author(s)Madeline Colli, Erin McEvoy
Filmed onsite at Cannabis Science Conference Spring 2023, Eloise Theisen shares perspectives and insider information from her profession.
Advertisement
Chief Nursing Officer and Board President of Leaf 411, nurse practitioner Eloise Theisen presented “Using Cannabinoids to Reduce Daily Opioid Milligram Equivalent (OME) in Palliative Care Patients with Chronic Pain: Case Reviews” at the conference. In this interview, she shares key takeaways from her presentation, her hopes for patients, and her hope for healthcare practitioners and the cannabis industry.
Advertisement
Related to this article
Let’s take a look at the 2025 cannabis coverage on medical cannabis research and medicine to catch up on industry trends and innovations.
Our top cannabis news topics this week: President Trump’s executive order on cannabis rescheduling, hemp regulation legislation, NY program using cannabis to reduce opioid use, cannabis genetics and cannabinoid profiles, and the latest cannabis research studies.
This month’s webinar explored published research studies on cannabis and its effect on opioids, substance use reduction, alcohol use, and autism symptoms.
President Trump signed an executive order directing federal agencies to reclassify cannabis from Schedule I to Schedule III controlled substances.
A recent study found that medical cannabis may play a role in decreasing opioid use.
The review analyzed more than 2,500 articles, finding inconsistent evidence for certain conditions and an increased risk for harm.
Our top cannabis news topics this week: Texas medical cannabis, first Native American-owned East Coast cannabis brand, pivoting with hemp manufacturing, low-dose CBD and stress, and alcohol-induced liver disease.
Advertisement
Advertisement